迄今,丙型肝炎病毒(hepatitis C virus,HCV)感染仍是一个重要的全球性公共卫生问题。由于HCV进入人体后起病隐匿,早期常无明显的肝功能受损表现,在体内不易被免疫系统清除,慢性化概率较高,也是肝硬化、原发性肝癌(HCC)等疾病的主要祸首之一[1]。由于HCV传染性强且缺乏有效的疫苗,加之病毒在健康献血员中感染的潜隐性和感染后漫长的无症状携带期[2]以及血液透 To date, hepatitis C virus (HCV) infection remains an important global public health problem. Since HCV enters the human body, its onset is insidious, there is usually no obvious impairment of liver function in the early stage, it is not easily cleared by the immune system in the body, and the probability of chronicity is high. It is also the main culprit of diseases such as cirrhosis and primary liver cancer (HCC). One [1]. Because HCV is contagious and lacks an effective vaccine, combined with the latent infection of the virus in healthy blood donors and the long asymptomatic period of infection after infection [2] and hemodialysis